When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. CVS Health pulls some cough-and-cold treatments with ...

    www.aol.com/news/cvs-health-pulls-cough-cold...

    CVS Health is pulling from its shelves some cough-and-cold treatments that contain an ingredient that has been deemed ineffective by doctors and researchers. The drug store chain said it will ...

  3. CVS to pull some cold, cough products with phenylephrine off ...

    www.aol.com/news/cvs-health-pull-decongestants...

    CVS Health will remove from its shelves certain oral cough and cold products with phenylephrine as the only active ingredient, the U.S. pharmacy chain said on Thursday. A panel of advisers to the ...

  4. CVS is under pressure and considering a breakup. Here's why ...

    www.aol.com/news/cvs-under-pressure-considering...

    CVS is the top U.S. pharmacy in terms of prescription drug revenue, holding more than 25% of the market share in 2023, according to Statista data released in March. Walgreens trailed behind with ...

  5. How misguided M&A damaged America’s drugstores - AOL

    www.aol.com/finance/inside-cvs-walgreens...

    Last week, CVS Health CEO Karen Lynch was pushed out of a role that had made her the most powerful woman in American business for years, atop a company with 2023 revenue of $358 billion. The ...

  6. Guaifenesin - Wikipedia

    en.wikipedia.org/wiki/Guaifenesin

    Guaifenesin might act as an expectorant by increasing the volume and reducing the viscosity of secretions in the trachea and bronchi via stimulation of the gastric mucosa. . This stimulation leads to an increased parasympathetic activity in the respiratory tract via the so-called gastro-pulmonary reflex, although some in vitro studies suggested that it might also act directly on the ...

  7. Is CVS Health Stock a Buy? - AOL

    www.aol.com/cvs-health-stock-buy-135600631.html

    That momentum helped fuel a record quarter for pharmacy sales during which CVS filled 432 million subscriptions, up 9% from Q3 2023, increasing its market share of scripts filled nationally to 27.3%.

  8. CVS needs ‘realistic targets’ it can exceed says analyst ...

    www.aol.com/finance/cvs-needs-realistic-targets...

    By late 2022, Lynch helped lift CVS’s share price from $70 to roughly $110, and investors were onboard with her new strategy: Making CVS a one-stop shop for basic care, Fortune’s Shawn Tully ...

  9. Luden's - Wikipedia

    en.wikipedia.org/wiki/Luden's

    Luden's Honey-Licorice Cough Drops. Luden's is an American brand of cough drop that is currently manufactured and sold in the US by Prestige Consumer Healthcare. Company headquarters are in Tarrytown, New York. Luden's products include Blue Raspberry, Honey Lemon, Honey Licorice, Kiwi-Strawberry, Orange, Original Menthol, Sugar-Free Wild Cherry ...